2025-03-29 13:22:53
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
Rossari Biotech Ltd Q2FY22 consolidated net profit up at Rs. 26.22 crore
Posted On : 2021-11-04 18:51:04( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 388.478 crores during the period ended September 30, 2021 as compared to Rs. 234.181 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 26.229 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 24.522 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 4.74 for the period ended September 30, 2021 as compared to Rs. 4.49 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 388.478 crs | ₹234.181 crs |  65.89% |
| Net Profit | ₹26.229 crs | ₹24.522 crs | 6.96% |
| EPS | ₹4.74 | ₹4.49 | 5.57% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 388.478 crores during the period ended September 30, 2021 as compared to Rs.175.625 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.26.229 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.20.698 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.4.74 for the period ended September 30, 2021 as compared to Rs.4.02 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 388.478 crs | ₹175.625 crs | 121.20% |
| Net Profit | ₹26.229 crs | ₹20.698 crs | 26.72% |
| EPS | ₹4.74 | ₹4.02 | 17.91% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.622.659 crores during the 6 Months period ended September 30, 2021 as compared to Rs.286.690 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.50.751 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.36.192 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.9.23 for the 6 Months period ended September 30, 2021 as compared to Rs.7.02 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹622.659 crs | ₹286.690 crs | 117.19% |
| Net Profit | ₹50.751 crs | ₹36.192 crs | 40.23% |
| EPS | ₹9.23 | ₹7.02 | 31.48% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 1352.20 as compared to the previous close of Rs. 1336.55. The total number of shares traded during the day was 3981 in over 687 trades.
The stock hit an intraday high of Rs. 1361.35 and intraday low of 1343.95. The net turnover during the day was Rs. 5392307.00.
